SIGA Technologies
SIGA
#8955
Rank
NZ$0.35 B
Marketcap
NZ$4.96
Share price
-4.21%
Change (1 day)
-52.26%
Change (1 year)

Earnings for SIGA Technologies (SIGA)

Earnings in 2026 (TTM): -NZ$18.79 Million

According to SIGA Technologies's latest financial reports the company's current earnings are NZ$53.65 Million. In 2025 the company made an earning of NZ$43.07 Million a decrease over its 2024 earnings that were of NZ$0.12 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for SIGA Technologies from 1997 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$18.79 Million-143.6%
2025 NZ$43.07 M-66.13%
2024 NZ$0.12 B-16.31%
2023 NZ$0.15 B89.48%
2022 NZ$80.21 M-50.38%
2021 NZ$0.16 B16.22%
2020 NZ$0.13 B1268.64%
2019 NZ$10.16 M-98.69%
2018 NZ$0.77 B-1912.24%
2017 -NZ$42.84 Million-7.91%
2016 -NZ$46.52 Million-30.38%
2015 -NZ$66.82 Million-82.62%
2014 -NZ$0.39 Billion796.54%
2013 -NZ$42.88 Million5.18%
2012 -NZ$40.77 Million-28.53%
2011 -NZ$57.04 Million
2009 -NZ$21.59 Million35.95%
2008 -NZ$15.88 Million17.07%
2007 -NZ$13.57 Million9.58%
2006 -NZ$12.38 Million168.94%
2005 -NZ$4.61 Million-71.48%
2004 -NZ$16.14 Million67.71%
2003 -NZ$9.63 Million57.35%
2002 -NZ$6.12 Million3.73%
2001 -NZ$5.9 Million-54.2%
2000 -NZ$12.88 Million105.09%
1999 -NZ$6.28 Million-33.58%
1998 -NZ$9.46 Million477.78%
1997 -NZ$1.64 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sarepta Therapeutics
SRPT
-NZ$0.24 Billion 1,075.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
-NZ$0.41 Billion 1,905.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-NZ$0.6 Billion 2,825.40%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
-NZ$14.94 Million-26.21%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-NZ$0.65 Billion 3,084.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-NZ$0.36 Billion 1,647.19%๐Ÿ‡บ๐Ÿ‡ธ USA